Why new precision oncology treatments benefit patients of some ancestries more than others
Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...
Targeted Oncology1h
Resistance Spurs Evaluation of Early-Phase BTK Degraders
During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to overcome ...
Renal & Urology News3h
Testosterone Therapy May Not Up Prostate Cancer Recurrence Risk
Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.
ORYZON to Provide Corporate Progress Updates at Several Events in January-February
Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events ...
Walla Walla Union Bulletin5hOpinion
Commentary: Should alcoholic beverages feature a warning about cancer risk?
U.S. Surgeon General Vivek Murthy issued a new report on alcohol and cancer, which emphasizes the risk of cancer in ...
Hosted on MSN13h
New Discovery Sheds Light on How Monoamines Regulate Brain Rhythms
A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help ...
Labroots23h
Artificial Intelligence Helps Predict Therapeutic Responses
Artificial intelligence (AI) is pushing the boundaries in therapeutic medicine. AI is the general term that refers to machine ...